Medical management of early fetal demise using sublingual misoprostol.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 12013170.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim of this study was to determine the efficacy of mifepristone in combination with sublingual misoprostol for the medical management of early fetal demise. Fifty-six consecutive women were studied prospectively. The mean (SD) gestation at diagnosis was 9.6 weeks (1.84). Four women had complete miscarriage with mifepristone alone. The overall success rate was 83.9% and the median induction-miscarriage interval was 8.19 hours (range 0.83 to 37.50 hours). Of those women who had a successful outcome, 91.5% were satisfied with the regimen. Sublingual misoprostol in combination with mifepristone is an effective and safe alternative to vaginal or oral misoprostol in the management of early fetal demise.
Medical subject headings
- Abortifacient Agents, Nonsteroidal
- Abortifacient Agents, Steroidal
- Abortion, Induced
- Fetal Death
- Mifepristone
- Misoprostol